Scarica l'app Stockscreener
81.83
0.83%
0.67
Dopo l'orario di chiusura:
81.83
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EW Giù?
Forum
Previsione
Frazionamento azionario
Edwards Lifesciences Corp Borsa (EW) Ultime notizie
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Leerink Partners raises Edwards Lifesciences stock price target on share buyback - Investing.com
Leerink Partners Adjusts PT on Edwards Lifesciences to $85 From $84, Maintains Market Perform Rating - MarketScreener
Edwards Lifesciences Corporation (EW) Announces Accelerated Shar - GuruFocus
Edwards Lifesciences Reports $500 Million Accelerated Share Buyback - MarketScreener
Edwards Lifesciences announces $500 million accelerated share repurchase - Investing.com
Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase - MarketScreener
Achieve Life Sciences, Inc. shares fall 2.44% intraday amid FTC's challenge to Edwards Lifesciences Corp.'s acquisition of JenaValve Technology, Inc. - AInvest
Edwards Lifesciences exec Wood sells $698k in shares - Investing.com
FTC Sues to Block Edwards LifeSciences Medical Device Deal - MSN
Edwards Lifesciences’ TRISCEND II Trial: A Game-Changer in Tricuspid Valve Treatment? - MSN
Stock Analysis | Edwards Lifesciences OutlookNavigating Mixed Signals in a Volatile Landscape - AInvest
Edwards Lifesciences Hits $0.2B Trade Volume Amid Trial Progress Ranks 479th in Daily Activity - AInvest
Edwards Lifesciences’ ENCIRCLE Trial: A New Hope for Mitral Regurgitation Patients - TipRanks
Edwards Lifesciences’ TRISCEND Study: A Game-Changer in Tricuspid Valve Replacement? - TipRanks
FTC Moves to Block Edwards Lifesciences’ $945 Million Acquisition of JenaValve Over Competition Concerns - MSN
FTC to block Edwards Lifesciences’ acquisition of JenaValve due to competitive concerns - Yahoo Finance
FTC seeks to block Edwards Lifesciences' acquisition of JenaValve - MSN
Edwards Lifesciences Rebounds on Institutional Buys Despite Securities Probe as $220M Volume Ranks Among Top 500 - AInvest
Edwards Lifesciences Advances with SAPIEN X4 Heart Valve Study - TipRanks
EDWARDS (EW) ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Edwards Lifesciences Rises 0.97% Amid 427th-Ranked Trading Volume as Fundamentals and Technicals Clash - AInvest
Moody’s revises Edwards Lifesciences outlook to positive, affirms Baa2 - Investing.com
Moody’s revises Edwards Lifesciences outlook to positive, affirms Baa2 By Investing.com - Investing.com Canada
Edwards Lifesciences Stock: Analyst Estimates & Ratings - Barchart.com
Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Edwards Lifesciences Ranks 458th in Trading Volume as Institutional Splits and High-Return Strategy Highlight Volatile Market Dynamics - AInvest
FTC Sounds Alarm On Edwards' Attempt To Corner Heart Device Market - Benzinga
Edwards Lifesciences Leads Heart Device Market With Value Upside - Finimize
Edwards Lifesciences’ ALT-FLOW II Trial: A Key Update for Heart Failure Treatment - TipRanks
Baird Adjusts Price Target on Edwards Lifesciences to $81 From $79, Maintains Neutral Rating - MarketScreener
FTC moves to block Edwards’ acquisition of JenaValve Technology - Medical Buyer
FTC seeks to block Edwards Lifesciences’ acquisition of JenaValve - WKZO
Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insigh - GuruFocus
FTC sues to block Edwards Lifesciences purchase of JenaValve - MSN
FTC seeks to block Edwards Lifesciences' acquisition of JenaValve | Business Information & News | FE - Westlaw Today
Bank Groups Urge Congress to Close ‘Loopholes’ in GENIUS Act - PYMNTS.com
FTC Files Lawsuit to Block Edwards Lifesciences’ Purchase of JenaValve Technology - The Wall Street Journal
Edwards Lifesciences' deal with JenaValve would limit device access, US FTC says - MLex
FTC moves to block Edwards Lifesciences’ JenaValve acquisition - MassDevice
JenaValve Responds to FTC’s Action Against Proposed Edwards Lifesciences Acquisition - The Manila Times
Jenavalve disagrees with FTC's decision against proposed Edwards Lifesciences deal - MarketScreener
FTC seeks to block Edwards Lifesciences’ acquisition of JenaValve By Reuters - Investing.com
2.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):